NLRP3 and sarcopenia: Overall, the connection between SASP and NLRP3 provides a scenario where therapeutic targets against senescent cells (senolytics) and/or the NLRP3 inflammasome could prevent muscle degeneration and sarcopenia, killing two birds with one stone.